Evidence map›Paper›PMID 28653675›Full record

ArticleProstate cancer and prostatic diseases2017

Periprostatic adipose inflammation is associated with high-grade prostate cancer.

A Gucalp, N M Iyengar, X K Zhou, D D Giri, D J Falcone, H Wang, S Williams, M D Krasne, I Yaghnam, B Kunzel and 9 more

Abstract read
In one paragraph

Article in Prostate cancer and prostatic diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 2 countries.

A GucalpDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
N M IyengarDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
X K ZhouDepartment of Healthcare Policy and Research, Weill Cornell Medical College, New York, NY, USA.
D D GiriDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
D J FalconeDepartment of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA.
H WangDepartment of Healthcare Policy and Research, Weill Cornell Medical College, New York, NY, USA.
S WilliamsDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0001-5558-5585
M D KrasneDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
I YaghnamDepartment of Medicine, Weill Cornell Medical College, New York, NY, USA.
B KunzelDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
P G MorrisDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
L W JonesDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
M PollakDepartments of Medicine and Oncology, McGill University, Montreal, Quebec, Canada.
V P LaudoneDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
C A HudisDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
H I ScherDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
P T ScardinoDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
J A EasthamDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
A J DannenbergDepartment of Medicine, Weill Cornell Medical College, New York, NY, USA.
Memorial Sloan Kettering Cancer Center · USCornell University · USMcGill University · CA

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Elisa de Stanchina · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

backgroundObesity, a cause of subclinical inflammation, is associated with increased risk of high-grade prostate cancer (PC) and poor outcomes. Whether inflammation occurs in periprostatic white adipose tissue (WAT), and contributes to the negative impact of obesity on PC aggressiveness, is unknown.

methodsIn a single-center, cross-sectional design, men with newly diagnosed PC undergoing radical prostatectomy were eligible for study participation. The primary objective was to examine the prevalence of periprostatic WAT inflammation defined by the presence of crown-like structures (CLS-P) as detected by CD68 immunohistochemistry. Secondary objectives were to explore the clinical and systemic correlates of periprostatic WAT inflammation. Tumor characteristics and host factors including BMI, adipocyte diameter, and circulating levels of lipids, adipokines, and other metabolic factors were measured. Wilcoxon rank-sum, Chi-square, or Fisher's exact tests, and generalized linear regression were used to examine the association between WAT inflammation and tumor and host characteristics.

resultsPeriprostatic fat was collected from 169 men (median age 62 years; median BMI 28.3). Periprostatic WAT inflammation was identified in 49.7% of patients and associated with higher BMI (P=0.02), larger adipocyte size (P=0.004) and Gleason grade groups IV/V tumors (P=0.02). The relationship between WAT inflammation and high Gleason grade remained significant after adjusting for BMI (P=0.04). WAT inflammation correlated with higher circulating levels of insulin, triglycerides, and leptin/adiponectin ratio, and lower high density lipoprotein cholesterol, compared to those without WAT inflammation (P's <0.05).

conclusionPeriprostatic WAT inflammation is common in this cohort of men with PC and is associated with high-grade PC.

Indexed as

Adipose Tissue, WhiteAgedBody Mass IndexHumansInflammationMaleMiddle AgedNeoplasm GradingObesityProstateProstatectomyProstatic Neoplasms

Identifiers

PMID28653675
PMCPMC5681425
OpenAlexW2731572658

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.